West Pharmaceutical Services Inc (NYSE:WST)
| 272.21 Delayed Data As of Oct 30 |  -3.02 / -1.10%Today’s Change | 124.53 Today|||52-Week Range 303.14 | +81.07% Year-to-Date |
Latest WST News | Press Releases
Today’s Trading
| Previous close | 275.23 |
| Today’s open | 274.74 |
| Day’s range | 265.19 - 275.83 |
| Volume | 439,107 |
| Average volume (3 months) | 508,202 |
| Market cap | $20.7B |
Data as of 4:00pm ET, 10/30/2020
Growth & Valuation
| Earnings growth (last year) | +16.66% |
| Earnings growth (this year) | +40.25% |
| Earnings growth (next 5 years) | +13.23% |
| Revenue growth (last year) | +7.31% |
| P/E ratio | 65.9 |
| Price/Sales | 6.15 |
| Price/Book | 13.20 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TFXTeleflex Inc | -8.94 | -2.74% |
| PODDInsulet Corp | -6.33 | -2.77% |
| ZBHZimmer Biomet Holdin... | -1.75 | -1.31% |
| ABMDABIOMED Inc | -2.68 | -1.05% |
Data as of 4:00pm ET, 10/30/2020
Financials
| Next reporting date | February 18, 2021 |
| EPS forecast (this quarter) | $1.13 |
| Annual revenue (last year) | $1.8B |
| Annual profit (last year) | $241.7M |
| Net profit margin | 13.11% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Exton, Pennsylvania |
Forecasts
